Literature DB >> 26720324

Addressing End-of-Life Quality Gaps in Hematologic Cancers: The Importance of Early Concurrent Palliative Care.

Thomas W LeBlanc1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 26720324     DOI： 10.1001/jamainternmed.2015.6994

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  17 in total

Review 1.  Early Palliative Care for Patients with Hematologic Malignancies: Is It Really so Difficult to Achieve?

Authors:  Thomas W LeBlanc; Eric J Roeland; Areej El-Jawahri
Journal:  Curr Hematol Malig Rep       Date:  2017-08       Impact factor: 3.952

2.  Advance care planning and end-of-life care for patients with hematologic malignancies who die after hematopoietic cell transplant.

Authors:  E E Eckhert; K L Schoenbeck; D Galligan; L M McNey; J Hwang; G N Mannis
Journal:  Bone Marrow Transplant       Date:  2017-03-13       Impact factor: 5.483

3.  The Surprise Question and Identification of Palliative Care Needs among Hospitalized Patients with Advanced Hematologic or Solid Malignancies.

Authors:  Kathryn Elizabeth Hudson; Steven Paul Wolf; Gregory P Samsa; Arif H Kamal; Amy Pickar Abernethy; Thomas William LeBlanc
Journal:  J Palliat Med       Date:  2018-02-08       Impact factor: 2.947

4.  Transfusion practices at end of life for hematopoietic stem cell transplant patients.

Authors:  Winnie S Wang; Joseph D Ma; Sandahl H Nelson; Carolyn Revta; Gary T Buckholz; Carolyn Mulroney; Eric J Roeland
Journal:  Support Care Cancer       Date:  2017-12-28       Impact factor: 3.603

Review 5.  Palliative and End-of-Life Care in Myelodysplastic Syndromes.

Authors:  Myles Nickolich; Areej El-Jawahri; Thomas W LeBlanc
Journal:  Curr Hematol Malig Rep       Date:  2016-12       Impact factor: 3.952

6.  Patient-Reported Distress in Myelodysplastic Syndromes and Its Association With Clinical Outcomes: A Retrospective Cohort Study.

Authors:  Jesse D Troy; Carlos M de Castro; Mary Ruth Pupa; Greg P Samsa; Amy P Abernethy; Thomas W LeBlanc
Journal:  J Natl Compr Canc Netw       Date:  2018-03       Impact factor: 11.908

7.  Adherence to Measuring What Matters Items When Caring for Patients With Hematologic Malignancies Versus Solid Tumors.

Authors:  Thomas W LeBlanc; Christine S Ritchie; Fred Friedman; Janet Bull; Jean S Kutner; Kimberly S Johnson; Arif H Kamal
Journal:  J Pain Symptom Manage       Date:  2016-11-01       Impact factor: 3.612

8.  Intensity of End-of-Life Care for Patients with Hematologic Malignancies and the Role of Race/Ethnicity.

Authors:  Kedar Kirtane; Lois Downey; Stephanie J Lee; J Randall Curtis; Ruth A Engelberg
Journal:  J Palliat Med       Date:  2018-07-05       Impact factor: 2.947

9.  End-of-life care quality outcomes among Medicare beneficiaries with hematologic malignancies.

Authors:  Pamela C Egan; Thomas W LeBlanc; Adam J Olszewski
Journal:  Blood Adv       Date:  2020-08-11

10.  The impact of remission status on patients' experiences with acute myeloid leukemia (AML): an exploratory analysis of longitudinal patient-reported outcomes data.

Authors:  Neha Kayastha; Steven P Wolf; Susan C Locke; Gregory P Samsa; Areej El-Jawahri; Thomas W LeBlanc
Journal:  Support Care Cancer       Date:  2017-11-18       Impact factor: 3.603
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.